/Tom Fleming
The importance of automation and high-quality data in drug discovery
The importance of automation and high-quality data in drug discovery
29 Nov 2019

In this video, Tom Fleming, Co-Founder and COO of Arctoris, discusses the development of the start-up’s fully-automated platform, which aims to provide biotechnology companies access to high-quality and reliable drug discovery data. Fleming was awarded the ELRIG Early Careers Professional Impact Award, as sponsored by SelectScience.

Related Scientists

Related Content